Experimental confirmation of antimicrobial effects of GdYVO4:Eu3+ nanoparticles

Drug Dev Ind Pharm. 2021 Dec;47(12):1966-1974. doi: 10.1080/03639045.2022.2075007. Epub 2022 May 15.

Abstract

Nanotechnology can be applied to design antibacterial agents to combat antibiotic resistance. The aim of the present study was to assess the antimicrobial effects and cytotoxicity of GdYVO4:Eu3+ nanoparticles (NPs). Biofilm inhibition activity, antimicrobial activity, bacterial viability inhibition and DNA cleavage activity of GdYVO4:Eu3+ NPs were studied. In addition, the impact of GdYVO4:Eu3+ NPs on the mitochondrial membrane potential (ΔΨM) of host immune cells and, hence, their apoptosis was analyzed by JC-1 staining using flow cytometry. GdYVO4:Eu3+ NPs demonstrated good antimicrobial, cell viability inhibition and DNA cleavage activities. In addition, GdYVO4:Eu3+ NPs showed good biofilm inhibition activity against S. aureus and P. aeruginosa and inhibition percentages were 89.15% and 79.54%, respectively. However, GdYVO4:Eu3+ NPs promoted mitochondrial depolarization and apoptosis of leukocytes at high concentrations. GdYVO4:Eu3+ nanoparticles are promising antibacterial agents. However, more efforts should be exerted to ensure their safety.

Keywords: DNA cleavage; JC-1; antimicrobial activity; bacterial viability; biofilm inhibition activity; mitochondrial membrane potential; nanoparticles.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents* / pharmacology
  • Biofilms
  • Metal Nanoparticles*
  • Microbial Sensitivity Tests
  • Nanoparticles*
  • Pseudomonas aeruginosa
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents